How can we improve clinical research in pneumonia?

Current Opinion in Pulmonary Medicine
Julio A Ramirez

Abstract

The primary challenges in the field of clinical research include a lack of support within existing infrastructure, insufficient number of clinical research training programs and a paucity of qualified mentors. Most medical centers offer infrastructure support for investigators working with industry sponsors or government-funded clinical trials, yet there are a significant amount of clinical studies performed in the field of pneumonia which are observational studies. For this type of research, which is frequently unfunded, support is usually lacking. In an attempt to optimize clinical research in pneumonia, at the University of Louisville, we developed a clinical research coordinating center (CRCC). The center manages clinical studies in the field of respiratory infections, with the primary focus being pneumonia. Other activities of the CRCC include the organization of an annual clinical research training course for physicians and other healthcare workers, and the facilitation of international research mentoring by a process of connecting new pneumonia investigators with established clinical investigators. To improve clinical research in pneumonia, institutions need to have the appropriate infrastructure in place to support inve...Continue Reading

References

Mar 14, 2003·JAMA : the Journal of the American Medical Association·Nancy S SungDavid Rimoin
Aug 30, 2006·Journal of Psychosomatic Research·Valsamma Eapen, Abu Adem
Jan 10, 2008·JAMA : the Journal of the American Medical Association·Steven H Woolf
Oct 15, 2008·Circulation·P Michael HoFrederick A Masoudi
Jan 1, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·T WiemkenJ Ramirez
Jul 13, 2013·The European Respiratory Journal·Joaquín BurgosAlbert Pahissa
Mar 19, 2015·The New England Journal of Medicine·Marc J M BontenDiederick E Grobbee
Apr 2, 2015·The New England Journal of Medicine·Douwe F PostmaUNKNOWN CAP-START Study Group
Apr 18, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Takashi TagamiHideo Yasunaga
Jun 28, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M CarugatiS Aliberti
Jul 15, 2015·The New England Journal of Medicine·Seema JainUNKNOWN CDC EPIC Study Team
Aug 25, 2015·American Heart Journal·Vicente F Corrales-MedinaJulio A Chirinos
Jan 10, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Naomi J GadsbyKate E Templeton
Apr 14, 2017·Journal of the American Geriatrics Society·Emanuela CataudellaLorenzo Malatino
May 19, 2017·The Journal of Infectious Diseases·Anna M BramleyUNKNOWN Centers for Disease Control and Prevention Etiology of Pneumonia in the Community (EPIC) Study Team
Jun 9, 2017·Critical Care : the Official Journal of the Critical Care Forum·Adrien MirouseEmmanuel Canet
Jul 2, 2017·Pulmonary Pharmacology & Therapeutics·Stefano AlibertiFrancesco Blasi
Oct 12, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Anna M M van DeursenElisabeth A M Sanders
Oct 12, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Julio A RamirezUNKNOWN University of Louisville Pneumonia Study Group

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Ámbito De Encuentros
Lillian Arvelo Márquez, Nilda G Medina Santiago
Nursing Standard
Kathleen Duffy
The Journal of Nursing Administration
L A Darling
© 2022 Meta ULC. All rights reserved